Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients

References

• Scott RB, Robb-Smith AH. Histiocytic medullary reticulocytosis. Lancet. 1939;234:194–198. doi: 10.1016/S0140-6736(00)61951-7
   Google Scholar
• Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–131. doi: 10.1002/pbc.21039
   PubMed Web of Science ®Google Scholar
• Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957–1959. doi: 10.1126/science.286.5446.1957
   PubMed Web of Science ®Google Scholar
• Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461–473. doi: 10.1016/S0092-8674(03)00855-9
   PubMed Web of Science ®Google Scholar
• zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827–834. doi: 10.1093/hmg/ddi076
   PubMed Web of Science ®Google Scholar
• zur Stadt U, Rohr J, Seifert W, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482–492. doi: 10.1016/j.ajhg.2009.09.005
   PubMed Web of Science ®Google Scholar
• Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233–246. doi: 10.1146/annurev-med-041610-134208
   PubMed Web of Science ®Google Scholar
• Daver N, McClain K, Allen CE, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017;123:3229–3240. doi: 10.1002/cncr.30826
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383:1503–1516. doi: 10.1016/S0140-6736(13)61048-X
   PubMed Web of Science ®Google Scholar
• Minoia F, Davì S, Horne A, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66:3160–3169. doi: 10.1002/art.38802
   PubMed Web of Science ®Google Scholar
• Créput C, Galicier L, Buyse S, et al. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 2008;34:1177–1187. doi: 10.1007/s00134-008-1111-y
   PubMed Web of Science ®Google Scholar
• Riviere S, Galicier L, Coppo P, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127:1118–1125. doi: 10.1016/j.amjmed.2014.04.034
   PubMed Web of Science ®Google Scholar
• Yoon JH, Park SS, Jeon YW, et al. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019;104:269–276. doi: 10.3324/haematol.2018.198655
   PubMed Web of Science ®Google Scholar
• Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015;90:220–224. doi: 10.1002/ajh.23911
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Oberti M, Skert C, et al. Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients. Hematol Oncol. 2017;35:828–834. doi: 10.1002/hon.2314
   PubMed Web of Science ®Google Scholar
• Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89:484–492. doi: 10.1016/j.mayocp.2013.12.012
   PubMed Web of Science ®Google Scholar
• Schram AM, Comstock P, Campo M, et al. Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. Br J Haematol. 2016;172:412–419. doi: 10.1111/bjh.13837
   PubMed Web of Science ®Google Scholar
• Buyse S, Teixeira L, Galicier L, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med. 2010;36:1695–1702. doi: 10.1007/s00134-010-1936-z
   PubMed Web of Science ®Google Scholar
• Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58–65. doi: 10.1532/IJH97.07012
   PubMed Web of Science ®Google Scholar
• Yu JT, Wang CY, Yang Y, et al. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann Hematol. 2013;92:1529–1536. doi: 10.1007/s00277-013-1784-3
   PubMed Web of Science ®Google Scholar
• Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore). 2014;93:100–105. doi: 10.1097/MD.0000000000000022
   PubMed Web of Science ®Google Scholar
• Li F, Yang Y, Jin F, et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis. 2015;10:20. doi: 10.1186/s13023-015-0224-y
   PubMed Web of Science ®Google Scholar
• Zhou M, Li L, Zhang Q, et al. Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis. QJM. 2018;111:23–31. doi: 10.1093/qjmed/hcx183
   PubMed Web of Science ®Google Scholar
• Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol. 2015;168:63–68. doi: 10.1111/bjh.13102
   PubMed Web of Science ®Google Scholar
• Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126:582–588. doi: 10.1182/blood-2014-08-531582
   PubMed Web of Science ®Google Scholar
• Bernardo A, Ball C, Nolasco L, et al. Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J Thromb Haemost. 2005;3:562–570. doi: 10.1111/j.1538-7836.2005.01122.x
   PubMed Web of Science ®Google Scholar
• Del Conde I, Crúz MA, Zhang H, et al. Platelet activation leads to activation and propagation of the complement system. J Exp Med. 2005;201:871–879. doi: 10.1084/jem.20041497
   PubMed Web of Science ®Google Scholar
• Eriksson O, Mohlin C, Nilsson B, et al. The human platelet as an innate immune cell: interactions between activated platelets and the complement system. Front Immunol. 2019;10:1590. doi: 10.3389/fimmu.2019.01590
   PubMed Web of Science ®Google Scholar
• Bigenwald C, Fardet L, Coppo P, et al. A comprehensive analysis of Lymphoma- associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis. Br J Haematol. 2018;183:68–75. doi: 10.1111/bjh.15506
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018;13:27–49. doi: 10.1146/annurev-pathol-020117-043625
   PubMed Web of Science ®Google Scholar
• Dao AT, Luong VT, Nguyen TT, et al. Risk factors for early fatal outcomes among children with hemophagocytic lymphohistiocytosis (HLH): a single-institution case-series in Vietnam. Pediatr Hematol Oncol. 2014;31:271–281. doi: 10.3109/08880018.2013.858198
   PubMed Web of Science ®Google Scholar
• Standage SW, Filipoovich AH. Hemophagocytic lymphohistiocytosis syndromes. Pediatr Crit Care Med. 2014;26:385–393. doi: 10.1007/978-1-4471-6416-6_26
   Google Scholar
• Bhat NS, Oshrine B, An Talano J. Hemophagocytic lymphohistiocytosis in adults. Leuk Lymphoma. 2019;60:19–28. doi: 10.1080/10428194.2018.1482543
   PubMed Web of Science ®Google Scholar
• Schram AM, Campigotto F, Mullally A, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125:1548–1552. doi: 10.1182/blood-2014-10-602607
   PubMed Web of Science ®Google Scholar
• Nabergoj M, Marinova M, Binotto G, et al. Diagnostic and prognostic value of low percentage of glycosylated ferritin in acquired hemophagocytic lymphohistiocytosis: A single-center study. Int J Lab Hematol. 2017;39:620–624. doi: 10.1111/ijlh.12713
   PubMed Web of Science ®Google Scholar
• Huang SC, Chen JS, Cheng CN, et al. Hypoalbuminaemia is an independent predictor for hemophagocytic lymphohistiocytosis in childhood Epstein-Barr virus-associated infectious mononucleosis. Eur J Haematol. 2012;89:417–422. doi: 10.1111/ejh.12006
   PubMed Web of Science ®Google Scholar
• Bin Q, Gao JH, Luo JM. Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases. Ann Hematol. 2016;95:1411–1418. doi: 10.1007/s00277-016-2727-6
   PubMed Web of Science ®Google Scholar
• Luo ZB, Chen YY, Xu XJ, et al. Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis. Cytokine. 2017;97:80–85. doi: 10.1016/j.cyto.2017.03.013
   PubMed Web of Science ®Google Scholar
• Tang Y, Xu X, Song H, et al. Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome. Br J Haematol. 2008;143:84–91. doi: 10.1111/j.1365-2141.2008.07298.x
   PubMed Web of Science ®Google Scholar
• Lorenz F, Klimkowska M, Pawłowicz E, et al. Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience. Leuk Lymphoma. 2018;59:1840–1850. doi: 10.1080/10428194.2017.1403018
   PubMed Web of Science ®Google Scholar